NRX Pharmaceuticals, Inc. Current Liabilities
NRX Pharmaceuticals, Inc. (NRXP) had Current Liabilities of $33.87 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $33.87M.
- 2026-03-31: Liabilities, Current $25.18M.
- 2025-12-31: Liabilities, Current $28.58M.
- 2025-09-30: Liabilities, Current $40.59M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $33.87M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $25.18M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $28.58M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $40.59M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $40.45M 10-Q · filed 2025-08-18 | |
| 2025-03-31 | $32.75M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $21.86M 10-K · filed 2026-03-23 | |
| 2024-09-30 | $20.30M 10-Q · filed 2024-11-14 | |
| 2023-12-31 | $19.05M 10-K · filed 2025-03-14 | |
| 2023-09-30 | $19.33M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $22.62M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $22.06M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $15.59M 10-K · filed 2024-03-29 | |
| 2021-12-31 | $11.92M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $36.77M 10-Q/A · filed 2022-08-12 | $36.28M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $57.80M 10-Q/A · filed 2022-08-12 | $35.47M 10-Q · filed 2021-08-16 |
| 2020-12-31 | $46.16M 10-Q/A · filed 2022-08-12 | |
| 2020-09-30 | $379.20K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $297.24K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $316.38K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $622.44K 10-Q · filed 2020-11-16 | |
| 2019-09-30 | $641.75K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $521.15K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $494.39K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $567.41K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $375.57K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $217.45K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $65.12K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $93.17K 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |